Increased survival and reduced renal injury in MRL/lpr mice treated with a human Fcγ receptor II (CD32) peptide.

Published in:

Immunology, 2012, v. 136, n. 1, p. 46, doi. 10.1111/j.1365-2567.2012.03553.x

By:

• Xi, Jun;
• Zhang, Gai P.;
• Qiao, Song L.;
• Guo, Jun Q.;
• Wang, Xuan N.;
• Yang, Yan Y.;
• Zhang, Li N.;
• Miao, Xian W.;
• Zhao, Dong;
• Zhi, Yu B.;
• Cai, Shu J.;
• Luo, Jun;
• Deng, Rui G.

Publication type:

Article